RiceBran Technologies (NASDAQ:RIBT) has been given a consensus broker rating score of 3.00 (Hold) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold rating.
Zacks has also given RiceBran Technologies an industry rank of 75 out of 256 based on the ratings given to related companies.
Shares of NASDAQ RIBT opened at $2.85 on Wednesday. RiceBran Technologies has a fifty-two week low of $1.58 and a fifty-two week high of $3.87. The company has a current ratio of 4.22, a quick ratio of 4.00 and a debt-to-equity ratio of 0.09.
RiceBran Technologies (NASDAQ:RIBT) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.10) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.03). RiceBran Technologies had a negative net margin of 53.57% and a negative return on equity of 38.80%. The business had revenue of $6.36 million during the quarter.
In other RiceBran Technologies news, major shareholder Grain Co Continental purchased 666,667 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were acquired at an average price of $3.00 per share, with a total value of $2,000,001.00. Following the transaction, the insider now owns 6,279,702 shares in the company, valued at $18,839,106. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 10.18% of the stock is currently owned by company insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Creative Planning purchased a new stake in RiceBran Technologies in the 1st quarter valued at about $41,000. Charles Schwab Investment Management Inc. purchased a new stake in RiceBran Technologies in the 1st quarter valued at about $47,000. Northern Trust Corp increased its stake in RiceBran Technologies by 24.5% in the 1st quarter. Northern Trust Corp now owns 22,861 shares of the company’s stock valued at $85,000 after buying an additional 4,497 shares during the last quarter. BlueCrest Capital Management Ltd purchased a new stake in RiceBran Technologies in the 1st quarter valued at about $85,000. Finally, Morgan Stanley increased its stake in RiceBran Technologies by 183.5% in the 1st quarter. Morgan Stanley now owns 34,126 shares of the company’s stock valued at $127,000 after buying an additional 22,090 shares during the last quarter. 30.02% of the stock is currently owned by institutional investors and hedge funds.
RiceBran Technologies Company Profile
RiceBran Technologies processes and markets healthy, natural, and nutrient dense products derived from raw rice bran. The company manufactures and distributes stabilized rice bran (SRB) in various granulations with other products and derivatives. It offers RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich derivative of RiBalance; and protein and protein/fiber blends under the ProRyza brand.
See Also: What is a Swap?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RiceBran Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiceBran Technologies and related companies with MarketBeat.com's FREE daily email newsletter.